Bain Capital Public Equity Management, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$24,196,000
-51.6%
906,201
-12.7%
0.72%
-44.4%
Q2 2015$49,976,000
-50.3%
1,038,355
-37.1%
1.30%
-48.1%
Q1 2015$100,484,000
-6.8%
1,651,335
-20.7%
2.50%
-7.4%
Q4 2014$107,782,000
-14.4%
2,081,932
-27.3%
2.70%
-16.5%
Q3 2014$125,958,000
+68.4%
2,862,0250.0%3.23%
+78.2%
Q2 2014$74,813,0000.0%2,862,0250.0%1.81%
-9.0%
Q1 2014$74,813,000
+82.4%
2,862,025
+18.4%
1.99%
+71.9%
Q4 2013$41,026,000
-18.1%
2,417,535
+3.6%
1.16%
-7.7%
Q3 2013$50,073,0002,333,3331.26%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders